Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison

Primaquine 30 mg/day versus 15 mg/day during 14 days for the prevention of Plasmodium vivax relapses in adults in French Guiana: a historical comparison

Abstract Background The preventive treatment of Plasmodium vivax relapse recommended by the World Health Organization is primaquine at a dose of 15 mg/day for 14 days, except for malaria cases from Asia and Oceania. Since 2006, CDC recommends the use of primaquine at 30 mg/day for 14 days. In France...

Full description

Bibliographic Details
Main Authors: Audrey Valdes, Loic Epelboin, Emilie Mosnier, Gaelle Walter, Guillaume Vesin, Philippe Abboud, Alessia Melzani, Denis Blanchet, Nicaise Blaise, Mathieu Nacher, Magalie Demar, Felix Djossou
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Malaria Journal
Subjects:
Plasmodium vivax
Malaria
Relapse
Primaquine
French Guiana
Online Access:http://link.springer.com/article/10.1186/s12936-018-2378-2

Internet

http://link.springer.com/article/10.1186/s12936-018-2378-2

Similar Items